S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ATNM Actinium Pharmaceuticals Inc

1.16

-0.01 (-0.85%)

Feb 24 2025 - Closed

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Actinium Pharmaceuticals (AMEX:ATNM)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Actinium Pharmaceuticals Charts.

Actinium Pharmaceuticals (AMEX:ATNM)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Actinium Pharmaceuticals Charts.

Actinium Pharmaceuticals Inc News

Form 8-K - Current report
Wednesday 27 November 2024 (3 months ago) • Edgar (US Regulatory)

Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024
Monday 18 November 2024 (3 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 8 November 2024 (4 months ago) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Wednesday 6 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 5 November 2024 (4 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Tuesday 5 November 2024 (4 months ago) • Edgar (US Regulatory)

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
Monday 4 November 2024 (4 months ago) • PR Newswire (US)

Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology
Friday 20 September 2024 (5 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

More Actinium Pharmaceuticals Inc News Articles

TPT Global Tech (PK)

Accredited Solutions (PK)

Intergrated Cannabis Sol... (PK)

Valiant Eagle (PK)

Lightwave Logic

NioCorp Developments

Asia Broadband (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions